Abstract
Background: Use of non-steroidal anti-inflammatory drugs (NSAIDs) remains controversial in patients with ulcerative colitis. Some evidence suggests NSAID use in patients with IBD may precipitate disease flares or increase surgical complications, and many clinicians prohibit their use. In the post-operative setting, ketorolac has been utilized to improve pain control since pathologic tissue has been removed. The clinical outcomes and narcotic requirements of children who receive ketorolac in …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
